Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis-Reference-Cited by-同舟云学术

Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis

Published:2024-01 Issue:1 Volume:6 Page:100958
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Saldarriaga Omar A.^ORCID,Wanninger Timothy G.,Arroyave Esteban^ORCID,Gosnell Joseph^ORCID,Krishnan Santhoshi,Oneka Morgan,Bao Daniel^ORCID,Millian Daniel E.,Kueht Michael L.^ORCID,Moghe Akshata,Jiao Jingjing,Sanchez Jessica I.,Spratt Heidi,Beretta Laura^ORCID,Rao Arvind,Burks Jared K.,Stevenson Heather L.^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference44 articles.

1. A multi-society Delphi consensus statement on new fatty liver disease nomenclature;Rinella;Hepatology,2023

2. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances;Noureddin;Am J Gastroenterol,2018

3. Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease;Laursen;Expert Opin Ther Targets,2022

4. Nonalcoholic steatohepatitis: a review;Sheka;JAMA,2020

5. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics;Livers;2024-09-13

2. Macrophage-based cancer immunotherapy: Challenges and opportunities;Experimental Cell Research;2024-09